Center for Scientific Review; Notice of Closed Meetings, 90022 [2024-26427]
Download as PDF
<![CDATA[
90022
Federal Register / Vol. 89, No. 220 / Thursday, November 14, 2024 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
Contact Person: Ombretta Salvucci, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W264, Rockville,
Maryland 20850, 240–276–7286, salvucco@
mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Institutional
Training and Education Study Section (F).
Date: February 11–12, 2025.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W234, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W234, Rockville, Maryland 20850,
240–276–6368, Stoicaa2@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI SPORE
(P50) Review SEP–III.
Date: February 25–26, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W514, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Wlodek Lopaczynski,
M.D., Ph.D., Assistant Director, Office of the
Director, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W514, Rockville,
Maryland 20850, 240–276–6340, lopacw@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI U54–
SPORE–SEP II.
Date: March 5–6, 2025.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Cancer Institute at
Shady Grove, 9609 Medical Center Drive,
Room 7W522, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Klaus B. Piontek, Ph.D.,
Chief, Research Programs Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W522, Rockville, Maryland
20850, 240–276–5413, klaus.piontek@
nih.gov.
(Catalogue of Federal Domestic
Assistance Program Nos. 93.392, Cancer
Construction; 93.393, Cancer Cause and
Prevention Research; 93.394, Cancer
Detection and Diagnosis Research;
93.395, Cancer Treatment Research;
93.396, Cancer Biology Research;
93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of
Health, HHS)
VerDate Sep<11>2014
20:16 Nov 13, 2024
Jkt 265001
Dated: November 8, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–26497 Filed 11–13–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Biological Chemistry and Biophysics.
Date: December 2, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Razvan Liviu Cornea,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 904L,
Bethesda, MD 20892, (301) 480–1955,
cornearl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Fogarty HIV Research Training Program for
Low- and Middle-Income Country
Institutions.
Date: December 5–6, 2024.
Time: 12:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ross D. Shonat, MS, Ph.D.,
BS Division Director, DPPS Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4100,
MSC 7814, Bethesda, MD 20892, (301) 435–
2786, ross.shonat@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–MH–
25–140: Streamlining mental health
interventions for youth living with HIV in
low and middle-income countries.
Date: December 6, 2024.
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Time: 10:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elia E. Ortenberg, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108,
Bethesda, MD 20892, 301–827–7189,
femiaee@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: HIV/AIDS Interventions and
Population and Public Health Approaches.
Date: December 6, 2024.
Time: 1:45 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elia E. Ortenberg, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108,
Bethesda, MD 20892, 301–827–7189,
femiaee@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 7, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–26427 Filed 11–13–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Novel and Exceptional
Technology and Research Advisory
Committee.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting should notify the Contact
Person listed below in advance of the
meeting. The meeting will be videocast
and can be accessed from the NIH
Videocasting and Podcasting website
(https://videocast.nih.gov/).
Name of Committee: Novel and
Exceptional Technology and Research
Advisory Committee.
E:\FR\FM\14NON1.SGM
14NON1
]]>Agencies
[Federal Register Volume 89, Number 220 (Thursday, November 14, 2024)]
[Notices]
[Page 90022]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26427]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Biological Chemistry and Biophysics.
Date: December 2, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Razvan Liviu Cornea, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 904L, Bethesda, MD 20892, (301)
480-1955, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Fogarty HIV Research Training Program for Low- and
Middle-Income Country Institutions.
Date: December 5-6, 2024.
Time: 12:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ross D. Shonat, MS, Ph.D., BS Division Director,
DPPS Center for Scientific Review, National Institutes of Health,
6701 Rockledge Drive, Room 4100, MSC 7814, Bethesda, MD 20892, (301)
435-2786, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-MH-25-140: Streamlining mental health interventions for
youth living with HIV in low and middle-income countries.
Date: December 6, 2024.
Time: 10:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elia E. Ortenberg, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108, Bethesda, MD 20892, 301-
827-7189, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: HIV/AIDS Interventions and Population and
Public Health Approaches.
Date: December 6, 2024.
Time: 1:45 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elia E. Ortenberg, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108, Bethesda, MD 20892, 301-
827-7189, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: November 7, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-26427 Filed 11-13-24; 8:45 am]
BILLING CODE 4140-01-P
